How does the Annex I shape the Environmental Monitoring strategy in your sterile facility?
Effective June 30, 2022, the registration procedure for Food Supplement notification in Italy has changed.
The US Breakthrough Device Designation Program can help your company speeding up your Medical Devices development, assessment and review.
MDUFA V is the latest amendment to the to the MDUFA Act, and it could bring an exceptional growth to the MD Community in the US.
LIMS solutions can help your business in reaching new levels of efficiency and automation in your laboratory.
Regulated companies are moving to Cloud solutions to store data, improving their performance and capability, while keeping a careful GxP oriented.
EMA has recommended the suspension of around 100 generic drugs for Data Integrity and Reliability issues, with the consequence of repeating the.
To guarantee high quality of standards in production, every investment in the medical cannabis production should take into consideration a.
Technologically up to date Greenhouse facilities, that respects the standards for medical cannabis production, ensure high productivity and.
The Point of Care is a new approach for which drugs production sites should be as much close as possible to patients, to reduce the product lead.
